Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03674242
Title Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 1st Line Treatment of TNBC (TRYbeCA-2)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors ERYtech Pharma
Indications
Therapies
Age Groups: senior | adult
Covered Countries HUN | ESP | BEL

Facility Status City State Zip Country Details
ZNA Middelheim Antwerpen Belgium Details
Institut Jules Bordet Brussels Belgium Details
UZ Brussel Brussels Belgium Details
Grand Hôpital de Charleroi asbl Charleroi Belgium Details
Clinique Sainte-Elisabeth Namur Belgium Details
Debreceni Egyetem - Klinikai Kozpont - Onkologiai Klinika Debrecen Hungary Details
Bacs Kiskun Megyei Korhaz Kecskemét 6000 Hungary Details
Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet Szolnok 5000 Hungary Details
Hospital Universitario Germans Trias i Pujol Badalona Spain Details
Complejo Hospitalario Universitario A Coruña La Coruña Spain Details
Hospital Universitario Arnau Vilanova Lleida Spain Details
Fundacion Jimenez Diaz Madrid Spain Details
Hospital Clinico San Carlos Madrid Spain Details
Hospital Universitario Quirón Madrid Madrid Spain Details
Hospital Universitario Ramon y Cajal Madrid Spain Details
Hospital Universitario Virgen del Rocio Sevilla Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field